William McGee to Neuromuscular Blocking Agents
This is a "connection" page, showing publications William McGee has written about Neuromuscular Blocking Agents.
Connection Strength
0.287
-
Murray MJ, DeBlock HF, Erstad BL, Gray AW, Jacobi J, Jordan CJ, McGee WT, McManus C, Meade MO, Nix SA, Patterson AJ, Sands K, Pino RM, Tescher AN, Arbour R, Rochwerg B, Murray CF, Mehta S. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient: 2016 update-executive summary. Am J Health Syst Pharm. 2017 Jan 15; 74(2):76-78.
Score: 0.138
-
Murray MJ, DeBlock H, Erstad B, Gray A, Jacobi J, Jordan C, McGee W, McManus C, Meade M, Nix S, Patterson A, Sands MK, Pino R, Tescher A, Arbour R, Rochwerg B, Murray CF, Mehta S. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient. Crit Care Med. 2016 Nov; 44(11):2079-2103.
Score: 0.136
-
Murray MJ, Cowen J, DeBlock H, Erstad B, Gray AW, Tescher AN, McGee WT, Prielipp RC, Susla G, Jacobi J, Nasraway SA, Lumb PD. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2002 Jan; 30(1):142-56.
Score: 0.012